The acquisition gives AstraZeneca full global control of the therapy’s development, manufacturing and commercialisation.

Women’s cardiovascular health has long been overlooked and understudied. Here are some things to keep in mind.

Fresh off of a European approval for a subcutaneous version of Saphnelo, AstraZeneca is doubling down on the benefits of the ...

Over 3.4 million people globally are affected by SLE, and it is one of the leading causes of death in young women in the US ...

For people living with lupus, pain can be one of the most persistent and difficult symptoms to manage. But the good news is that a combination of medical treatments, lifestyle changes and ...

A thorough patient history and physical exam are crucial for managing dacryoadenitis and any associated systemic disorders, ...

Eleven patients with refractory autoimmune hemolytic anemia (AIHA) were all brought into drug-free remission with CAR T-cell ...

Johnson & Johnson said it will initiate a Phase 3 trial of its treatment for systemic lupus erythematosus, or SLE, after a recent study of the therapy met its primary endpoint.

February is American Heart Month, a national observance dedicated to raising awareness about heart disease and encouraging ...

Recent findings suggest that the Epstein-Barr virus (EBV) is involved in both causing multiple sclerosis (MS) and shaping its ...

Private rheumatologist Dr Anandita Santosa in Singapore notes how current AI in healthcare priorities practically leave ...

Lupus is often marked by flares, which is when symptoms are usually more obvious.